Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/19/1994 | CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
10/19/1994 | CN1093711A Human placental nucleic acid preparation method and application thereof |
10/19/1994 | CN1093708A Azole derivatives |
10/19/1994 | CN1093707A Vinyleneazaindole derivatives |
10/19/1994 | CN1093706A Crystalline salts of optically active aminocoumaran derivaticves, their production and use |
10/19/1994 | CN1093705A 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1, 3-oxathiolanes; and 2,5-diaryl-1, 3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or.......... |
10/19/1994 | CN1093702A Phenyl-imidazolidinone derivatives and process for their preparation |
10/19/1994 | CN1093701A Antiretroviral hydrazine derivatives |
10/19/1994 | CN1093598A Use of Il-10 to preventor treat insulin-dependent diabetes mellitus |
10/19/1994 | CN1093589A Medicine for curing acne-"Fenciling" |
10/19/1994 | CN1093575A Bioenqineering of "meizhiti" life |
10/19/1994 | CN1093574A Medicine for curing thrombus |
10/19/1994 | CN1093573A Medicinal usage of calcium acetate and production method thereof |
10/19/1994 | CN1093572A Skin pain relieving liniment and preparation method thereof |
10/19/1994 | CN1093571A Parmaceutical agent |
10/19/1994 | CN1026236C Steroid 5-alpha-reductase inhibitors |
10/19/1994 | CN1026234C Hypoglycemic thiazolidinedione derivatives |
10/18/1994 | US5356934 Administering (R)-fluoxetine |
10/18/1994 | US5356932 Methods and compositions for controlling intraocular pressure with transition metal complexes |
10/18/1994 | US5356928 Tubulin binding, anticancer agents |
10/18/1994 | US5356927 Methods of treating plasmodium and babesia parasitic infections |
10/18/1994 | US5356926 Antiinflammatory agents |
10/18/1994 | US5356925 For cardiovascular and urogenital disorders |
10/18/1994 | US5356923 1-hydroxy-4(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone and anti-hypertensive use thereof |
10/18/1994 | US5356922 Treatment of disturbances in microcirculation |
10/18/1994 | US5356921 Imidazolylphenol compounds, pharmaceutical compositions containing them, and processes for preparing such compounds and compositions |
10/18/1994 | US5356920 Anticholesterol, antilipemic agent |
10/18/1994 | US5356918 Oxazolidinone compounds and method of using the same as a vasodilator |
10/18/1994 | US5356916 1,2,4-oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity |
10/18/1994 | US5356915 Tetralones with pharmacological activity, compositions containing them |
10/18/1994 | US5356914 Cognition activators |
10/18/1994 | US5356913 Use of insulin sensitizing agents to treat hypertension |
10/18/1994 | US5356912 3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease |
10/18/1994 | US5356911 Hypotensive agents |
10/18/1994 | US5356910 Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder |
10/18/1994 | US5356909 Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments |
10/18/1994 | US5356907 1-cycloalkylpyridones as analgesics |
10/18/1994 | US5356906 (N-phthalimidoalkyl) piperidines useful as treatments for psychosis |
10/18/1994 | US5356905 Neuroprotective 3-piperidino-4-hydroxychroman derivatives and analogs |
10/18/1994 | US5356904 Carbostyril oxytocin receptor antagonists |
10/18/1994 | US5356900 Method of treating chronic herpes virus infections using an opiate receptor antagonist |
10/18/1994 | US5356898 Antiinflammatory agents, antiallergens, antiulcer agents |
10/18/1994 | US5356897 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines |
10/18/1994 | US5356896 Alkaline stabiling medium |
10/18/1994 | US5356895 1,4 piperizino inhibitors of non-enzymatic cross-linking of proteins |
10/18/1994 | US5356893 Benzanilide derivatives |
10/18/1994 | US5356892 Administering anticholinergic muscarinic antagonist to control abnormal postnatal growth of eye of animal |
10/18/1994 | US5356889 Carbapenicillins |
10/18/1994 | US5356888 1,1-dioxo-cephem-4-carbothiolic acid derivatives |
10/18/1994 | US5356887 Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids |
10/18/1994 | US5356886 Treating herpes virus infections |
10/18/1994 | US5356885 Substituted oxotremorine derivatives and pharmaceutical use thereof |
10/18/1994 | US5356882 Antiviral pyrimidine nucleosides |
10/18/1994 | US5356881 Plant-derived wildlife repellents |
10/18/1994 | US5356879 Administering to mammals; inhibition of formation of advanced glycosylation end-products; aging resistance |
10/18/1994 | US5356873 Method for providing nutritional requirements to patients having a chronic inflammation reaction |
10/18/1994 | US5356791 Mixing platelets or cancer cells with labelled platelet activating factor in presence of lipoproteins or cholesterol with and without antagonist, separating cells, measuring bound material |
10/18/1994 | US5356636 Using mixture of oil soluble active material, film forming colloid and reducing sugar |
10/18/1994 | US5356631 Pharmaceutical composition |
10/18/1994 | US5356620 Aqueous solution containing polyvinylpyrrolidone, base, surfactant, preservative; topical treatment of allergic conjunctivitis or rhinitis |
10/18/1994 | CA1332615C Anti-hypertensive sulfonanilides |
10/18/1994 | CA1332610C Furan derivatives |
10/18/1994 | CA1332609C 1,2-dithiol-3-thion-s-oxide compounds and pharmaceutical compositions |
10/18/1994 | CA1332608C N-phenylpyrazol-4-yl ether derivatives |
10/18/1994 | CA1332604C Carbocyclic compounds |
10/18/1994 | CA1332570C Method for reducing skin irritation associated with drug/penetration enhancer compositions |
10/18/1994 | CA1332569C Topical preparation |
10/18/1994 | CA1332568C Cosmetic composition |
10/18/1994 | CA1332567C Sustained release pharmaceutical composition |
10/18/1994 | CA1332566C Agent containing aminobenzoic acid derivative as an active ingredient having an activity to reduce side effects induced by an administration of immuno-suppressant |
10/18/1994 | CA1332556C Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2-phenoxyethyl)-ammonium bromide and methods of using the same |
10/17/1994 | CA2121425A1 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them |
10/17/1994 | CA2121323A1 1h-indole-3-acetamide spla2 inhibitors |
10/17/1994 | CA2121321A1 1h-indole-3-acetic acid hydrazide spla2 inhibitors |
10/17/1994 | CA2121167A1 Shampoo composition |
10/17/1994 | CA2120214A1 Compounds with benzamidic structure active in gastro-intestinal pathologies |
10/17/1994 | CA2094203A1 Inhibition of angiogenesis |
10/16/1994 | CA2121313A1 Heterocyclic iminobismethylenebisphosphonic acid derivatives |
10/14/1994 | CA2121112A1 New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
10/14/1994 | CA2120863A1 Production of dobutamine compounds |
10/13/1994 | WO1994023050A1 Targeted delivery of genes encoding antisense polyribonucleotides |
10/13/1994 | WO1994023048A2 Gibbon ape leukemia virus-based retroviral vectors |
10/13/1994 | WO1994023045A1 Method of inhibiting the transcription of genes |
10/13/1994 | WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
10/13/1994 | WO1994023028A2 Modified oligonucleotides having improved anti-influenza activity |
10/13/1994 | WO1994023015A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
10/13/1994 | WO1994023014A1 Tumoricide t lymphocytes |
10/13/1994 | WO1994022910A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
10/13/1994 | WO1994022909A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS |
10/13/1994 | WO1994022907A1 New urea derivates, their preparation and their use |
10/13/1994 | WO1994022899A1 New prednisolone derivates |
10/13/1994 | WO1994022898A1 New glucocorticoids |
10/13/1994 | WO1994022896A1 Cholestasis ameliorant |
10/13/1994 | WO1994022892A1 7-deazapurine modified oligonucleotides |
10/13/1994 | WO1994022891A1 Oligonucleotides with amide linkages replacing phosphodiester linkages |
10/13/1994 | WO1994022890A1 Novel 5'-substituted nucleosides and oligomers produced therefrom |
10/13/1994 | WO1994022888A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
10/13/1994 | WO1994022887A1 New antiviral compounds |
10/13/1994 | WO1994022885A1 Anticoagulant compounds |
10/13/1994 | WO1994022882A1 Unsaturated phosphonates derivatives of purines and pyrimidines |